EZZ Life Science (ASX: EZZ) has published financial results for the first half of the current financial year (H1 FY2022), with co-founder and interim chief executive officer Mark Qin saying the company was continuing its value-creating strategies. Mr Qin, who is also interim chief operating officer, said EZZ Life Science’s management team is confident about […]
The post EZZ Life Science seeks to build long-term value position in genomics appeared first on Small Caps.
from Small Caps https://ift.tt/y6gGmcL
إرسال تعليق